Cited by 62Cardiovascular Effects of ExerciseViral Infections and Immunology ResearchCardiomyopathy and Myosin Studies

Arrhythmogenic Right Ventricular Cardiomyopathy Presenting as Clinical Myocarditis in Women

Scheel, Paul J., Murray, Brittney, Tichnell, Crystal, James, Cynthia A., Tandri, Harikrishna, Calkins, Hugh, Chelko, Stephen P., Gilotra, Nisha A.·2021·The American Journal of Cardiology

Abstract

Patients with arrhythmogenic right ventricular cardiomyopathy (ARVC) classically initially present with ventricular arrhythmias or, less commonly, heart failure. Myocardial inflammation has been implicated in pathogenesis, but clinical myocarditis in ARVC is less described. We therefore studied clinical myocarditis as an initial ARVC presentation, and hypothesized that these patients have distinct clinical and genetic characteristics. Using the Johns Hopkins ARVC Registry, we identified 12 patients (all female, median age 20) referred between 2014 and 2019 diagnosed with myocarditis at presentation who were subsequently diagnosed with ARVC by Task Force Criteria. Majority presented with chest pain (n = 7, 58%) or ventricular arrhythmia (n = 3, 25%). All patients had troponin elevations and left ventricular (LV) function was reduced in 5 (42%). Magnetic resonance imaging demonstrated LV delayed gadolinium enhancement and/or pericardial enhancement in 10 (83%); only 3 (25%) patients had right ventricular abnormalities. Pathogenic genetic variants were identified in 11 (92%) patients: 10 desmoplakin (DSP) and 1 desmoglein-2 (DSG2). Thus, nearly 1/3 (10/32, 31%) of overall DSP ARVC patients were originally diagnosed with myocarditis. Patients were diagnosed with ARVC 1.8 years (IQR 2.7 years) after presentation and 8 (75%) patients did not meet Task Force Criteria without genetic testing. ARVC diagnosis led to an additional 5 (42%) patients referred for implantable cardiac defibrillator and 17 family member diagnoses. In conclusion, ARVC may initially present as myocarditis and these patients have distinct characteristics including female gender, LV involvement and DSP gene variants. Genetic testing is key to ARVC diagnosis and should be considered in select myocarditis patients.

Integrity signals

Registry

Crossref · 10.1016/j.amjcard.2020.12.090

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Scheel, P. J., Murray, B., Tichnell, C., James, C. A., Tandri, H., Calkins, H., Chelko, S. P., & Gilotra, N. A.
Affiliations
  • Johns Hopkins University (US)
  • Florida State University (US)
Corresponding author
Gilotra, Nisha A.
Venue
The American Journal of Cardiology
Publisher
Elsevier BV
Published
2021-04
Volume
145
Pages
128-134
ISSN
0002-9149 (ISSN-L)
OpenAlex
W3120991620
Cited by
62
References
6
Citations by year
2026: 11 · 2025: 7 · 2024: 6 · 2023: 12 · 2022: 17 · 2021: 9
FWCI
7.27
Type
journal article
Language
en
Open access
closed
Locations
  • The American Journal of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • American Heart Association (18TPA34170559)
  • Fondation Leducq
  • Johns Hopkins University
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Viral Infections and Immunology Research
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Keywords
arrhythmogenic right ventricular cardiomyopathy, myocarditis, clinical features, desmoplakin, desmoglein 2, genetic variants, left ventricular involvement, troponin elevation, late gadolinium enhancement, implantable cardioverter-defibrillator, family screening, women
MeSH terms
Adolescent, Adult, Biopsy, Child, Diagnostic Errors, Electrocardiography, Female, Genetic Testing, Humans, Magnetic Resonance Imaging, Middle Aged, Myocarditis, Myocardium, Pedigree, Phenotype, Registries, Sex Factors, Ventricular Dysfunction, Left, Arrhythmogenic Right Ventricular Dysplasia, Early Diagnosis, Desmoplakins, Desmoglein 2, Young Adult, Delayed Diagnosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review